The top 3 things:
Slower growth - bogged down by dividend payments so unable to reinvest all their retained earnings.
Stuck with an old business model - FXL is one of the pioneers in the BNPL space but they didn't realise that the cash cow is in lower valued, high frequency discretionary items. So they are stuck having to reinvent themselves, while their peers have had the chance to hit the ground running.
Higher default rates - Higher credit risk due to their higher valued longer timeframe products, and also less nimble than some of their peers like Afterpay which has a receivables turnover of 4 weeks.
- Forums
- ASX - By Stock
- HUM
- Buckle up for $2
Buckle up for $2, page-1473
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HUM (ASX) to my watchlist
|
|||||
Last
47.0¢ |
Change
0.020(4.44%) |
Mkt cap ! $230.9M |
Open | High | Low | Value | Volume |
45.0¢ | 47.0¢ | 45.0¢ | $203.3K | 443.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24990 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 28966 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24990 | 0.465 |
2 | 63000 | 0.460 |
2 | 74629 | 0.455 |
1 | 20001 | 0.450 |
1 | 44479 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 28966 | 4 |
0.475 | 14000 | 2 |
0.480 | 93369 | 3 |
0.485 | 20500 | 1 |
0.490 | 14039 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
HUM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online